- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Carbohydrate Metabolism Disorder
Total 160844 results
-
CENTOGENE GmbH RostockWithdrawnAlpha-Mannosidase B Deficiency | Lysosomal Alpha B Mannosidosis | Alpha-Mannosidase DeficiencyIndia, Sri Lanka, Germany
-
University Hospital, ToursCompletedMucopolysaccharidosesFrance
-
Dicerna Pharmaceuticals, Inc.CompletedPrimary Hyperoxaluria Type 3United States, Germany, Netherlands, United Kingdom
-
Zymenex A/SEuropean CommissionCompletedAlpha MannosidosisCzechia, Germany, Norway, United Kingdom
-
University of CologneCompletedPrimary Hyperoxaluria Type IGermany
-
Hospital Ruber InternacionalRecruitingRefractory Epilepsy | SLC35A2-CDG - Solute Carrier Family 35 Member A2 Congenital Disorder of GlycosylationSpain
-
Columbia UniversityEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsEnrolling by invitationMitochondrial Disease | Mitochondrial Disorders | Melas | Kearns Sayer | NARP | MNGIE | LHON | Mitochondrial Depletion Syndrome | Leigh's DiseaseUnited States
-
Helse Stavanger HFCompletedInsulin Resistance | Estrogen Receptor-positive Breast Cancer | Early-stage Breast Cancer | Carbohydrate Engorgement | Proliferation
-
Fujian Cancer HospitalCompletedCervical Cancer | Anesthesia | Carbohydrate | Tumor ImmunityChina
-
Instituto de Investigación Sanitaria de la Fundación...Biopolis S.L.; Adventia PharmaUnknownMalnutrition | Crohn Disease | Absorption; Disorder | Absorption; Disorder, Protein | Absorption; Disorder, Fat | Absorption; Disorder, CarbohydrateSpain
-
PTC TherapeuticsAxio Research. LLCCompleted
-
Cystinose StiftungScreening Laboratory Hannover; Pediatry Kastanienhof Koeln; Medical Genetics... and other collaboratorsRecruitingCystinosis | Primary HyperoxaluriaGermany
-
Ultragenyx Pharmaceutical IncAbeona Therapeutics, IncEnrolling by invitationMucopolysaccharidosis III-AUnited States, Australia, Spain
-
ArmaGen, IncCompletedMucopolysaccharidosis IBrazil
-
Abeona Therapeutics, IncTerminatedMucopolysaccharidosis III-BUnited States, Germany, France
-
Ultragenyx Pharmaceutical IncCompletedGlycogen Storage Disease Type IANetherlands, United States
-
Fondazione TelethonActive, not recruitingMucopolysaccharidosis Type VIItaly, Turkey
-
University of AberdeenCompletedMetabolism Disorder, GlucoseUnited Kingdom
-
University of Texas Southwestern Medical CenterNational Heart, Lung, and Blood Institute (NHLBI)RecruitingLipid Metabolism DisorderUnited States
-
Université de SherbrookeHospices Civils de LyonCompleted
-
Merck Sharp & Dohme LLCCompletedLipid Metabolism Disorder
-
University Hospital, Strasbourg, FranceRecruiting
-
ArmaGen, IncCompletedMucopolysaccharidosis I
-
Baylor Research InstituteUltragenyx Pharmaceutical IncCompletedAdult Polyglucosan Body Disease | Glycogen Brancher Enzyme Deficiency | Glycogen Storage Disease Type IVFrance
-
VA New York Harbor Healthcare SystemMayo Clinic; New York UniversityUnknownOxalate, Primary Hyperoxaluria, MicrobiomeUnited States
-
Huazhong University of Science and TechnologyUnknownCardiovascular Disease | Lactose MalabsorptionChina
-
Genzyme, a Sanofi CompanyBioMarin/Genzyme LLCCompletedMucopolysaccharidosis IBrazil, Russian Federation
-
Brain-Gut Research GroupCompletedIrritable Bowel Syndrome | Fructose IntoleranceSwitzerland
-
Taysha Gene Therapies, Inc.Withdrawn
-
Tanta UniversityRecruitingPreoperative Oral Carbohydrate Loading Versus Fasting in Patients Undergoing Major Abdominal SurgeryFasting | Major Abdominal Surgery | CarbohydrateEgypt
-
Liverpool John Moores UniversityCompletedEnergy Supply; Deficiency | Carbohydrate AvailabilityUnited Kingdom
-
Ultragenyx Pharmaceutical IncTerminatedGlucose Transporter Type 1 Deficiency Syndrome (Glut1 DS)United States, Spain, France, Germany, Italy, United Kingdom
-
Fondation Ophtalmologique Adolphe de RothschildCompleted
-
PTC TherapeuticsCompletedLeigh SyndromeUnited States
-
Aadi Bioscience, Inc.Withdrawn
-
JCR Pharmaceuticals Co., Ltd.RecruitingMucopolysaccharidosis III-AGermany
-
CinnagenCompletedMucopolysaccharidosis Type 1Iran, Islamic Republic of
-
Sangamo TherapeuticsTerminated
-
PATHFred Hutchinson Cancer CenterCompletedG6PD DeficiencyUnited States
-
University Medical Center GroningenUltragenyx Pharmaceutical IncCompletedGlycogen Storage Disease Type IANetherlands
-
PATHCompletedG6PD DeficiencyUnited States
-
University of MinnesotaNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); National... and other collaboratorsCompletedMucopolysaccharidosesUnited States
-
Baebies, Inc.CompletedG6PD Deficiency | G6PDUnited States
-
Ultragenyx Pharmaceutical IncCompletedGlucose Transporter Type 1 Deficiency Syndrome (Glut1 DS)United States, Spain, Australia, France, Israel, Italy, United Kingdom
-
Lundquist Institute for Biomedical Innovation at...National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); National... and other collaboratorsCompletedMucopolysaccharidosesUnited States
-
Nationwide Children's HospitalSanfilippo Children's Research Foundation; The Sanfilippo Research Foundation; The Children's Medical Research FoundationCompletedMucopolysaccharidosis Type IIIA | Mucopolysaccharidosis Type IIIBUnited States
-
Columbia UniversityCompletedMetabolism Disorder, GlucoseUnited States
-
Rocket Pharmaceuticals Inc.Not yet recruitingPyruvate Kinase DeficiencySpain, United States
-
Agios Pharmaceuticals, Inc.Active, not recruitingPyruvate Kinase DeficiencyUnited States, Spain, Japan, Canada, United Kingdom, Korea, Republic of, Ireland, Thailand, Italy, Turkey, Denmark, Brazil, France, Germany, Netherlands, Switzerland